{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:04:44Z","timestamp":1792073084850,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ceca.2020.102333","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T23:16:33Z","timestamp":1610493393000},"page":"102333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax\/Bak-independent cell death in B-cell cancers through mitochondrial Ca2+-dependent mPTP opening"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-9244","authenticated-orcid":false,"given":"Martijn","family":"Kerkhofs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"La Rovere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Welkenhuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4719-1935","authenticated-orcid":false,"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniswamy","family":"Madesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-4967","authenticated-orcid":false,"given":"Jan B.","family":"Parys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-4828","authenticated-orcid":false,"given":"Geert","family":"Bultynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ceca.2020.102333_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ceca.2020.102333_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.ceca.2020.102333_bib0015","first-page":"4438","article-title":"Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo","volume":"55","author":"Raffo","year":"1995","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ceca.2020.102333_bib0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.bjc.6605736","article-title":"BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received","volume":"103","author":"Dawson","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0025","first-page":"6","article-title":"Expression of bcl-2 in small cell lung carcinoma cells","volume":"54","author":"Ikegaki","year":"1994","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-018-0608-2","article-title":"BCL-2 as therapeutic target for hematological malignancies","volume":"11","author":"Perini","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.ceca.2020.102333_bib0035","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia","volume":"101","author":"Egle","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ceca.2020.102333_bib0045","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","article-title":"BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia","volume":"111","author":"Del Gaizo Moore","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ceca.2020.102333_bib0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/cdd.2017.183","article-title":"Why do BCL-2 inhibitors work and where should we use them in the clinic?","volume":"25","author":"Montero","year":"2018","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11523-020-00711-3","article-title":"Targeting apoptosis in acute myeloid leukemia: current status and future directions of BCL-2 inhibition with venetoclax and beyond","volume":"15","author":"Choi","year":"2020","journal-title":"Target. Oncol."},{"key":"10.1016\/j.ceca.2020.102333_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2736","article-title":"Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort","author":"Jelinek","year":"2020","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ceca.2020.102333_bib0075","doi-asserted-by":"crossref","first-page":"212574","DOI":"10.7573\/dic.212574","article-title":"Venetoclax: evidence to date and clinical potential","volume":"8","author":"Juarez-Salcedo","year":"2019","journal-title":"Drugs Context"},{"issue":"7","key":"10.1016\/j.ceca.2020.102333_bib0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.bbamcr.2013.01.021","article-title":"Non-apoptotic roles of Bcl-2 family: the calcium connection","volume":"1833","author":"Bonneau","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ceca.2020.102333_bib0085","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035089","article-title":"Bcl-2-Protein Family as Modulators of IP3 Receptors and Other Organellar Ca2+ Channels","volume":"12","author":"Ivanova","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"39","key":"10.1016\/j.ceca.2020.102333_bib0090","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1038\/onc.2016.31","article-title":"Bcl-2 proteins and calcium signaling: complexity beneath the surface","volume":"35","author":"Vervliet","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200309146","article-title":"Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate","volume":"166","author":"Chen","year":"2004","journal-title":"J. Cell Biol."},{"issue":"34","key":"10.1016\/j.ceca.2020.102333_bib0100","doi-asserted-by":"crossref","first-page":"55704","DOI":"10.18632\/oncotarget.11005","article-title":"The trans-membrane domain of Bcl-2alpha, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition","volume":"7","author":"Ivanova","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molcel.2008.06.014","article-title":"Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals","volume":"31","author":"Rong","year":"2008","journal-title":"Mol. Cell"},{"issue":"34","key":"10.1016\/j.ceca.2020.102333_bib0110","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1073\/pnas.0907555106","article-title":"The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor","volume":"106","author":"Rong","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.ceca.2020.102333_bib0115","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1007\/s00018-019-03091-8","article-title":"Bcl-2 and IP3 compete for the ligand-binding domain of IP3Rs modulating Ca2+ signaling output","volume":"76","author":"Ivanova","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.ceca.2020.102333_bib0120","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2010-09-307405","article-title":"Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction","volume":"117","author":"Zhong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ceca.2020.102333_bib0125","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/cddis.2013.140","article-title":"IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2","volume":"4","author":"Akl","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ceca.2020.102333_bib0130","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1038\/cddis.2015.355","article-title":"Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263","volume":"6","author":"Greenberg","year":"2015","journal-title":"Cell Death Dis."},{"issue":"29","key":"10.1016\/j.ceca.2020.102333_bib0135","doi-asserted-by":"crossref","first-page":"27388","DOI":"10.18632\/oncotarget.4489","article-title":"A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2","volume":"6","author":"Lavik","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2014.12.001","article-title":"Physiological and pathological roles of the mitochondrial permeability transition pore in the heart","volume":"21","author":"Kwong","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ceca.2020.102333_bib0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ceca.2017.05.004","article-title":"Calcium and regulation of the mitochondrial permeability transition","volume":"70","author":"Giorgio","year":"2018","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10863-016-9672-x","article-title":"Mitochondrial Ca2+ and regulation of the permeability transition pore","volume":"49","author":"Hurst","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"issue":"6","key":"10.1016\/j.ceca.2020.102333_bib0155","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1177\/0271678X20908523","article-title":"The cell-permeable mitochondrial calcium uniporter inhibitor Ru265 preserves cortical neuron respiration after lethal oxygen glucose deprivation and reduces hypoxic\/ischemic brain injury","volume":"40","author":"Novorolsky","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/acscentsci.8b00773","article-title":"A Selective and Cell-Permeable Mitochondrial Calcium Uniporter (MCU) Inhibitor Preserves Mitochondrial Bioenergetics after Hypoxia\/Reoxygenation Injury","volume":"5","author":"Woods","year":"2019","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ceca.2020.102333_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2018.07.020","article-title":"Targeting Bcl-2-IP3 receptor interaction to treat cancer: a novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones","author":"Distelhorst","year":"2018","journal-title":"Biochim. Biophys. Acta. Mol. Cell. Res"},{"issue":"9","key":"10.1016\/j.ceca.2020.102333_bib0175","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035196","article-title":"Creating a new Cancer Therapeutic agent by targeting the interaction between Bcl-2 and IP3 receptors","volume":"11","author":"Distelhorst","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"67","key":"10.1016\/j.ceca.2020.102333_bib0180","doi-asserted-by":"crossref","first-page":"111656","DOI":"10.18632\/oncotarget.22898","article-title":"Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax","volume":"8","author":"Vervloessem","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.ceca.2020.102333_bib0185","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/cdd.2014.84","article-title":"Mitochondrial Ca2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction","volume":"21","author":"Hwang","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ceca.2020.102333_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2014.08.018","article-title":"The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia\/reperfusion injury","volume":"78","author":"Halestrap","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.ceca.2020.102333_bib0195","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15252\/embr.201643354","article-title":"Ca2+ binding to F-ATP synthase beta subunit triggers the mitochondrial permeability transition","volume":"18","author":"Giorgio","year":"2017","journal-title":"EMBO Rep."},{"issue":"15","key":"10.1016\/j.ceca.2020.102333_bib0200","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1073\/pnas.1217823110","article-title":"Dimers of mitochondrial ATP synthase form the permeability transition pore","volume":"110","author":"Giorgio","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ceca.2020.102333_bib0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4161\/cc.23599","article-title":"Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition","volume":"12","author":"Bonora","year":"2013","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.ceca.2020.102333_bib0210","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embr.201643602","article-title":"Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation","volume":"18","author":"Bonora","year":"2017","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.ceca.2020.102333_bib0215","doi-asserted-by":"crossref","first-page":"eaaw4597","DOI":"10.1126\/sciadv.aaw4597","article-title":"Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD","volume":"5","author":"Karch","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ceca.2020.102333_bib0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00772","article-title":"Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice","volume":"2","author":"Karch","year":"2013","journal-title":"Elife"},{"issue":"17","key":"10.1016\/j.ceca.2020.102333_bib0225","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1073\/pnas.1201608109","article-title":"Bax regulates primary necrosis through mitochondrial dynamics","volume":"109","author":"Whelan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ceca.2020.102333_bib0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molcel.2009.01.018","article-title":"Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death","volume":"33","author":"Roy","year":"2009","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.ceca.2020.102333_bib0235","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2012.05.014","article-title":"p53 opens the mitochondrial permeability transition pore to trigger necrosis","volume":"149","author":"Vaseva","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","article-title":"BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents","volume":"12","author":"Deng","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ceca.2020.102333_bib0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fonc.2017.00174","article-title":"Mitochondria-associated membranes As networking platforms and regulators of Cancer cell fate","volume":"7","author":"Sassano","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ceca.2020.102333_bib0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-981-10-4567-7_4","article-title":"Endoplasmic Reticulum-Mitochondria Communication Through Ca(2+) Signaling: The Importance of Mitochondria-Associated Membranes (MAMs)","volume":"997","author":"Marchi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.ceca.2020.102333_bib0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41419-017-0179-0","article-title":"Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes","volume":"9","author":"Kerkhofs","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0260","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/s41467-019-11646-3","article-title":"IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer","volume":"10","author":"Bartok","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ceca.2020.102333_bib0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2019.00107","article-title":"Dysregulation of cell survival in diffuse large B cell lymphoma: mechanisms and therapeutic targets","volume":"9","author":"Miao","year":"2019","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ceca.2020.102333_bib0270","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.bbamcr.2014.12.006","article-title":"The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel","volume":"1853","author":"Vervloessem","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ceca.2020.102333_bib0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41418-018-0142-3","article-title":"Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2\/IP3 receptor disruptor BIRD-2","volume":"26","author":"Bittremieux","year":"2019","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.ceca.2020.102333_bib0280","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.celrep.2016.02.030","article-title":"Selective vulnerability of Cancer cells by inhibition of Ca(2+) transfer from endoplasmic reticulum to mitochondria","volume":"14","author":"Cardenas","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ceca.2020.102333_bib0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceca.2017.08.008","article-title":"The MCU complex in cell death","volume":"69","author":"Penna","year":"2018","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.ceca.2020.102333_bib0290","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cub.2012.11.026","article-title":"Downregulation of the mitochondrial calcium uniporter by cancer-related miR-","volume":"23","author":"Marchi","year":"2013","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.ceca.2020.102333_bib0295","doi-asserted-by":"crossref","first-page":"e2923","DOI":"10.1038\/cddis.2017.280","article-title":"MICU1 protects against myocardial ischemia\/reperfusion injury and its control by the importer receptor Tom70","volume":"8","author":"Xue","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ceca.2020.102333_bib0300","doi-asserted-by":"crossref","first-page":"1681254","DOI":"10.1155\/2019\/1681254","article-title":"Overexpression of mitochondrial calcium uniporter causes neuronal death","volume":"2019","author":"Granatiero","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.ceca.2020.102333_bib0305","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15252\/emmm.201606255","article-title":"The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1alpha","volume":"8","author":"Tosatto","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.ceca.2020.102333_bib0310","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/0008-5472.CAN-17-3082","article-title":"RIPK1 binds MCU to mediate induction of mitochondrial Ca(2+) uptake and promotes colorectal oncogenesis","volume":"78","author":"Zeng","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0315","first-page":"809","article-title":"TATfused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release","volume":"41","author":"Xie","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ceca.2020.102333_bib0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/cdd.2011.97","article-title":"Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl","volume":"19","author":"Monaco","year":"2012","journal-title":"Cell Death Differ."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416020301755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416020301755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:30:32Z","timestamp":1758918632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416020301755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":64,"alternative-id":["S0143416020301755"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2020.102333","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739372948.793582626","asserted-by":"object"}]},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax\/Bak-independent cell death in B-cell cancers through mitochondrial Ca2+-dependent mPTP opening","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2020.102333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102333"}}